Assessing SYmptom-driven versus Maintenance Preventer Therapy for the Outpatient Management of AsThma in Children

New national trial to find the best treatment for childhood asthma

Asthma affects over a million children in the UK, with the main symptoms being a cough and difficulty breathing. This happens because the airways narrow due to swelling and irritation.


Why are we doing this study?

Currently, the main treatment is a preventer inhaler, containing steroids, which prevents irritation of the airways. For many years, health professionals have been advising children with asthma to use their preventer inhaler every day to reduce symptoms and prevent attacks. However, new guidelines recommend that taking a preventer inhaler every day might not be required in all children. The new guidelines recommend that in mild asthma, inhalers could be taken only when symptoms occur. These changes are based on results of recent studies in adults, and some teenagers, with asthma.

In order to learn how best to treat children with mild asthma, a team led by researchers from the University of Liverpool have launched the clinical trial to find out if taking a preventer inhaler only when a child has symptoms is as effective as taking it every day.


Who can take part?

We are inviting all potentially suitable people to take part.

  • Aged 6-15 years inclusive
  • Mild asthma , including children with a new diagnosis. 
  • At least one relevant (for asthma) prescription of short acting beta agonists (SABA) or inhaled corticosteroids (ICS) in the last 12 months (including new diagnoses)